A move is afoot to have a historical marker erected in honor of a Pottsville man who was among the first volunteers to serve ...

Superb Sennheisers or the best of Bowers?

A Snake in the Shrine is the final mission in the Spymaster questline in the Claws of Awaji expansion for Assassin's Creed ...

Voting ended with a turnout of 41 per cent recorded by 3.30 pm; final figures are awaited. Counting of votes is scheduled for January 16, along with results for 29 other municipal corporations in ...

Lead candidate in the MLLT1/3 programme, DBT 3757, is a differentiated investigational molecule designed to treat Acute Myeloid Leukemia Acquisition brings a new therapeutic mechanism to Amgen's ...

Amgen is adding Dark Blue to its tapestry, embedding the U.K. biotech’s preclinical blood cancer program into its organization. The California pharma has stitched together a deal worth up to $840 ...

Amgen has acquired U.K.-based biotechnology company Dark Blue Therapeutics in a transaction valued at up to $840 million. Amgen on Tuesday said the deal adds an investigational small molecule that ...

This article first appeared on GuruFocus. Amgen (NASDAQ:AMGN) has agreed to acquire UK-based cancer drug developer Dark Blue Therapeutics in a deal valued at up to $840 million, as the company looks ...

In what is thought to be the first major pharma M&A deal of the year, Amgen has bought Oxford, UK-based biotech Dark Blue Therapeutics (DBT), which specialises in cancer therapies. The transaction – ...

THOUSAND OAKS, Calif., Jan. 6, 2026 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced its acquisition of Dark Blue Therapeutics Ltd., a privately held biotechnology company based in the United ...

Tudor’s latest Black Bay Chronograph features a striking “Flamingo Blue” dial, introducing a fresh aesthetic that’s reminiscent of tropical waters to brighten up the wintry months. Following the ...